Vitrolife

103,60 SEK

-0,67%

Mindre end 1K følgere

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vitrolife

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Omsætning960,03.609,0842,0871,0835,0892,03.440,0807,0
EBITDA337,0962,0257,0243,0253,0196,0949,0251,0
EBIT224,0783,0151,0137,0144,0-5.267,0-4.835,0149,0
EBIT-%23,3 %21,7 %17,9 %15,7 %17,2 %-590,5 %-140,6 %18,5 %
Overskud før skat183,0674,0141,0132,0131,0-5.290,0-4.886,0130,0
Netto indkomst140,0514,0100,0100,0102,0-5.315,0-5.013,0101,0